Having options can lower vaccine hesitancy, finds research
Consumers love having choices, even when it comes to vaccines, according to new research from the University of Oregon.
Apr 15, 2024
0
80
Amino Acids, Peptides, and Proteins: News and Research on Recombinant Proteins
MeSH tree: D12.776.828
Relative deficiency in immune cells can account for poorer vaccination responses in the older population
As we age, the immune system's efficacy weakens, leading to less effective defenses against new pathogens—such as the SARS-CoV-2 virus. How immunosenescence in older adults affects their immune response to COVID-19 mRNA vaccinations ...
Apr 3, 2024
0
48
Study explores characteristics associated with poor COVID-19 antibody response
Adults with certain socio-demographic and clinical characteristics may have weaker antibody responses to COVID-19 vaccination, which could leader to a higher risk of infection, according to a recent study published in Nature ...
Mar 22, 2024
0
101
Optimizing boosters: How COVID mRNA vaccines reshape immune memory after each dose
mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in combating coronavirus 19 (COVID-19). These vaccines work by triggering ...
Mar 8, 2024
0
50
Researchers investigate immune response of a man who received 217 COVID vaccinations
Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen have examined a man who has received more than 200 vaccinations against COVID-19. They learned of his case via newspaper ...
Mar 5, 2024
0
220
How to make mRNA therapeutics safe from the start
The success of mRNA vaccines against COVID-19 has unleashed a flood of interest in using the technology to create more vaccines and treatments for everything from rare diseases and infections to cancer.
Feb 28, 2024
0
61
Researchers examine the benefits of COVID-19 nasal spray vaccination
A research team at Freie Universität Berlin has conducted a comprehensive comparison of the efficacy of a mucosal, replication-competent but fully attenuated virus vaccine, sCPD9-ΔFCS, with the monovalent mRNA vaccine BNT162b2 ...
Feb 27, 2024
0
49
Study finds Moderna vaccine reduces symptomatic COVID-19 in young adults
The COVID-19 pandemic spurred the rapid development of different vaccines, including the messenger RNA (mRNA)-1273 vaccine produced by Moderna.
Feb 16, 2024
1
73
Combination of photonic sensors and microfluidics could detect cancer markers within 20 minutes
Russian scientists have proposed a new promising rapid way to diagnose breast cancer. It will spot the disease based on a blood test that takes between 15 and 20 minutes. The solution can be adapted to spot other diseases, ...
Jan 31, 2024
0
46
Breast milk may have potential protective effects against SARS-CoV-2, say researchers
The COVID-19 pandemic was an especially harrowing time for pregnant people and new parents.
Jan 29, 2024
0
39
